Logo image of LIN.DE

LINDE PLC (LIN.DE) Stock Fundamental Analysis

Europe - FRA:LIN - IE000S9YS762 - Common Stock

405 EUR
+2 (+0.5%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

5

Overall LIN gets a fundamental rating of 5 out of 10. We evaluated LIN against 68 industry peers in the Chemicals industry. While LIN has a great profitability rating, there are some minor concerns on its financial health. LIN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LIN had positive earnings in the past year.
LIN had a positive operating cash flow in the past year.
Each year in the past 5 years LIN has been profitable.
Each year in the past 5 years LIN had a positive operating cash flow.
LIN.DE Yearly Net Income VS EBIT VS OCF VS FCFLIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

The Return On Assets of LIN (7.80%) is better than 87.88% of its industry peers.
With an excellent Return On Equity value of 17.43%, LIN belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
LIN's Return On Invested Capital of 9.18% is fine compared to the rest of the industry. LIN outperforms 78.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LIN is above the industry average of 6.62%.
The 3 year average ROIC (8.64%) for LIN is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.8%
ROE 17.43%
ROIC 9.18%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.64%
ROIC(5y)7.15%
LIN.DE Yearly ROA, ROE, ROICLIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

LIN has a better Profit Margin (20.20%) than 98.48% of its industry peers.
LIN's Profit Margin has improved in the last couple of years.
LIN has a Operating Margin of 27.35%. This is amongst the best in the industry. LIN outperforms 98.48% of its industry peers.
In the last couple of years the Operating Margin of LIN has grown nicely.
With a decent Gross Margin value of 48.45%, LIN is doing good in the industry, outperforming 74.24% of the companies in the same industry.
LIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.35%
PM (TTM) 20.2%
GM 48.45%
OM growth 3Y15.4%
OM growth 5Y17.98%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
LIN.DE Yearly Profit, Operating, Gross MarginsLIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

LIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for LIN has been reduced compared to 1 year ago.
Compared to 5 years ago, LIN has less shares outstanding
Compared to 1 year ago, LIN has a worse debt to assets ratio.
LIN.DE Yearly Shares OutstandingLIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
LIN.DE Yearly Total Debt VS Total AssetsLIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 3.77 indicates that LIN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.77, LIN belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
The Debt to FCF ratio of LIN is 5.11, which is a neutral value as it means it would take LIN, 5.11 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.11, LIN is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
LIN has a Debt/Equity ratio of 0.64. This is a neutral value indicating LIN is somewhat dependend on debt financing.
LIN has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: LIN underperforms 62.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.11
Altman-Z 3.77
ROIC/WACC1.08
WACC8.49%
LIN.DE Yearly LT Debt VS Equity VS FCFLIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.93 indicates that LIN may have some problems paying its short term obligations.
LIN has a worse Current ratio (0.93) than 86.36% of its industry peers.
A Quick Ratio of 0.78 indicates that LIN may have some problems paying its short term obligations.
The Quick ratio of LIN (0.78) is worse than 74.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.78
LIN.DE Yearly Current Assets VS Current LiabilitesLIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

LIN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.62%.
The Earnings Per Share has been growing by 16.11% on average over the past years. This is quite good.
The Revenue has been growing slightly by 1.28% in the past year.
Measured over the past years, LIN shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)7.62%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%6.23%
Revenue 1Y (TTM)1.28%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%2.76%

3.2 Future

Based on estimates for the next years, LIN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.51% on average per year.
The Revenue is expected to grow by 5.04% on average over the next years.
EPS Next Y7.1%
EPS Next 2Y8.23%
EPS Next 3Y9.89%
EPS Next 5Y8.51%
Revenue Next Year1.97%
Revenue Next 2Y3.77%
Revenue Next 3Y4.46%
Revenue Next 5Y5.04%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIN.DE Yearly Revenue VS EstimatesLIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
LIN.DE Yearly EPS VS EstimatesLIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.00 indicates a quite expensive valuation of LIN.
Compared to the rest of the industry, the Price/Earnings ratio of LIN is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.38, LIN is valued at the same level.
Based on the Price/Forward Earnings ratio of 26.34, the valuation of LIN can be described as expensive.
Based on the Price/Forward Earnings ratio, LIN is valued a bit more expensive than 62.12% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, LIN is valued at the same level.
Industry RankSector Rank
PE 30
Fwd PE 26.34
LIN.DE Price Earnings VS Forward Price EarningsLIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LIN is valued a bit more expensive than the industry average as 69.70% of the companies are valued more cheaply.
LIN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.28
EV/EBITDA 18.69
LIN.DE Per share dataLIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIN does not grow enough to justify the current Price/Earnings ratio.
LIN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.22
PEG (5Y)1.86
EPS Next 2Y8.23%
EPS Next 3Y9.89%

3

5. Dividend

5.1 Amount

LIN has a Yearly Dividend Yield of 1.26%.
LIN's Dividend Yield is slightly below the industry average, which is at 3.03.
Compared to an average S&P500 Dividend Yield of 2.38, LIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

The dividend of LIN is nicely growing with an annual growth rate of 9.70%!
Dividend Growth(5Y)9.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

LIN pays out 40.71% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of LIN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.71%
EPS Next 2Y8.23%
EPS Next 3Y9.89%
LIN.DE Yearly Income VS Free CF VS DividendLIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
LIN.DE Dividend Payout.LIN.DE Dividend Payout, showing the Payout Ratio.LIN.DE Dividend Payout.PayoutRetained Earnings

LINDE PLC

FRA:LIN (9/19/2025, 7:00:00 PM)

405

+2 (+0.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners87.55%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap189.91B
Analysts78.06
Price Target442.85 (9.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend4.73
Dividend Growth(5Y)9.7%
DP40.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.03%
Min EPS beat(2)-0.37%
Max EPS beat(2)0.43%
EPS beat(4)3
Avg EPS beat(4)0.1%
Min EPS beat(4)-0.37%
Max EPS beat(4)0.43%
EPS beat(8)7
Avg EPS beat(8)0.58%
EPS beat(12)11
Avg EPS beat(12)2.21%
EPS beat(16)15
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)0.7%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)0.7%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)3
Avg Revenue beat(12)-2.09%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)-0.69%
PT rev (3m)-0.01%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0.23%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)1.02%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 30
Fwd PE 26.34
P/S 6.75
P/FCF 44.28
P/OCF 22.64
P/B 5.83
P/tB N/A
EV/EBITDA 18.69
EPS(TTM)13.5
EY3.33%
EPS(NY)15.37
Fwd EY3.8%
FCF(TTM)9.15
FCFY2.26%
OCF(TTM)17.89
OCFY4.42%
SpS59.99
BVpS69.5
TBVpS-2.49
PEG (NY)4.22
PEG (5Y)1.86
Profitability
Industry RankSector Rank
ROA 7.8%
ROE 17.43%
ROCE 12.74%
ROIC 9.18%
ROICexc 9.79%
ROICexgc 22.18%
OM 27.35%
PM (TTM) 20.2%
GM 48.45%
FCFM 15.25%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.64%
ROIC(5y)7.15%
ROICexc(3y)9.31%
ROICexc(5y)7.64%
ROICexgc(3y)23.08%
ROICexgc(5y)19.1%
ROCE(3y)11.99%
ROCE(5y)9.81%
ROICexcg growth 3Y14.81%
ROICexcg growth 5Y23.95%
ROICexc growth 3Y18.89%
ROICexc growth 5Y24.77%
OM growth 3Y15.4%
OM growth 5Y17.98%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.11
Debt/EBITDA 1.92
Cap/Depr 130.01%
Cap/Sales 14.57%
Interest Coverage 250
Cash Conversion 77.32%
Profit Quality 75.5%
Current Ratio 0.93
Quick Ratio 0.78
Altman-Z 3.77
F-Score5
WACC8.49%
ROIC/WACC1.08
Cap/Depr(3y)97.89%
Cap/Depr(5y)86.75%
Cap/Sales(3y)11.55%
Cap/Sales(5y)11.43%
Profit Quality(3y)100.43%
Profit Quality(5y)127.18%
High Growth Momentum
Growth
EPS 1Y (TTM)7.62%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%6.23%
EPS Next Y7.1%
EPS Next 2Y8.23%
EPS Next 3Y9.89%
EPS Next 5Y8.51%
Revenue 1Y (TTM)1.28%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%2.76%
Revenue Next Year1.97%
Revenue Next 2Y3.77%
Revenue Next 3Y4.46%
Revenue Next 5Y5.04%
EBIT growth 1Y8.79%
EBIT growth 3Y18.1%
EBIT growth 5Y21.73%
EBIT Next Year40.27%
EBIT Next 3Y16.75%
EBIT Next 5Y12.92%
FCF growth 1Y-6.18%
FCF growth 3Y-9.47%
FCF growth 5Y14.47%
OCF growth 1Y12.78%
OCF growth 3Y-1.05%
OCF growth 5Y8.77%